Advertisement
Long COVID has raised the profile of this long-challenging autoimmune condition
Recent FDA approval opens doors for new neurostimulation therapy
High-intensity cycling program leads to improved walking capacity and upper extremity function
Selective DHODH inhibitor designed as a better-tolerated alternative to teriflunomide
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Case study underscores the imperative for thorough evaluation with SEEG
Studies point to a range of neurological applications beyond movement disorders
New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study
New analysis details the disparities and points to opportunities for improvement
Black race, COVID-19 hospitalization and mood symptoms confer increased risk, study finds
Clinician-led online behavioral pain management class aims to transform standard of care
Advertisement
Advertisement